- Description
Description
EsmoCure 40mg
Each vial contains:
Esomeprazole sodium Eq. to Esomeprazole 40 mg
Excipient Q.S
Mechanism of action:
Esomeprazole is a weak base and is concentrated and converted to the active form in the highly acidic environment of the secretory canaliculi of the parietal cell, where it inhibits the enzyme H+K+-ATPase – the acid pump and inhibits both basal and stimulated acid secretion.
Indications:
Esomeprazole sodium for injection and infusion is indicated in adults for:
Gastric antisecretory treatment when the oral route is not possible, such as:
gastroesophageal reflux disease (GERD) in patients with esophagitis and/or severe symptoms of reflux.
healing of gastric ulcers associated with NSAID therapy.
prevention of gastric and duodenal ulcers associated with NSAID therapy, in patients at risk.
Prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers.
Esomeprazole sodium for injection and infusion is indicated in children and adolescents aged 1-18 years for:
Gastric antisecretory treatment when the oral route is not possible, such as:
gastroesophageal reflux disease (GERD) in patients with erosive reflux esophagitis and/or severe symptoms of reflux.
Gastric antisecretory treatment when the oral route is not possible, such as:
gastroesophageal reflux disease (GERD) in patients with esophagitis and/or severe symptoms of reflux.
healing of gastric ulcers associated with NSAID therapy.
prevention of gastric and duodenal ulcers associated with NSAID therapy, in patients at risk.
Prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers.
Esomeprazole sodium for injection and infusion is indicated in children and adolescents aged 1-18 years for:
Gastric antisecretory treatment when the oral route is not possible, such as:
gastroesophageal reflux disease (GERD) in patients with erosive reflux esophagitis and/or severe symptoms of reflux.
